Literature DB >> 9154947

Redistribution of amiodarone in heart transplant recipients treated with the drug before operation.

J N Nanas1, M I Anastasiou-Nana, Z J Margari, J Karli, S D Moulopoulos.   

Abstract

Seven heart transplant recipients (six men and one woman) treated with oral amiodarone 194 +/- 100 mg/day before operation for a period of 30 +/- 48.5 months were studied. The myocardial concentrations of amiodarone in the transplanted heart peaked in the second posttransplantation week (87.6 +/- 80.7 microg/g myocardial tissue) and remained detectable in the twelfth week (10.2 +/- 8.4 microg/g myocardial tissue). The ratio of myocardial/plasma concentrations peaked at the end of the sixth posttransplantation week. In conclusion, amiodarone accumulated rapidly in the transplanted myocardium of heart transplant recipients treated with the drug before operation and remained detectable for at least 3 months.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154947

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  3 in total

Review 1.  Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients.

Authors:  Douglas L Jennings; Brandon Martinez; Sheila Montalvo; David E Lanfear
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

2.  Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality.

Authors:  Lauren B Cooper; Robert J Mentz; Leah B Edwards; Amber R Wilk; Joseph G Rogers; Chetan B Patel; Carmelo A Milano; Adrian F Hernandez; Josef Stehlik; Lars H Lund
Journal:  J Heart Lung Transplant       Date:  2016-07-17       Impact factor: 10.247

3.  Discontinuing amiodarone treatment prior to heart transplantation lowers incidence of severe primary graft dysfunction.

Authors:  Benjamin Hoemann; Hiroo Takayama; Douglas L Jennings; Jiho Han; Masahiko Ando; Susan Restaino; Paolo Colombo; Maryjane Farr; Yoshifumi Naka; Koji Takeda
Journal:  Clin Transplant       Date:  2020-01-29       Impact factor: 2.863

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.